ziftomenib,venetoclax,azacitidine,daunorubicin,cytarabine
roche,abbvie,kura oncology
['myeloid', 'ko,met,007', 'komet,007', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'ko,met,07', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'leukemia', 'kura ']
the komet-007 combination trial for patients with #npm1-mutant or #kmt2a-rearranged acute myeloid leukemia (#aml) is expected to initiate this quarter. connect with our team at the annual meeting to learn about this clinical trial, &amp; our work in #precisiononcology. #asco23 
We're working to realize the promise of precision medicines. Our goal is to help patients with cancer lead longer, better lives.